The picture comes from the prospectus
Posted: Thu Feb 13, 2025 5:10 am
As of now, the five new stocks listed on the A-share market in 2025, namely, Xingtu Measurement & Control, C Saifen, Tianhe Magnetic Materials, C Junwei, and Huangshan Valley Jie, all closed higher on the first day, with an average increase of nearly 3 times on the first day of listing.
It can be seen that after A-share investors hit the new stocks and sell them on the first day of listing, there is a high probability of making money. Therefore, it is recommended to actively participate in the subscription of the above two new stocks.
The following is an introduction to the specific situation of these two companies.
Chaoyan Co., Ltd. is the "forefather" of ultrasound in my country, with a gross profit margin of over 66%
The full name of Chaoyan Co., Ltd. is "Shantou Ultrasonic dentist data Instrument Research Institute Co., Ltd." and its predecessor is the Ultrasonic Research Institute established in 1982. In 1983, the company independently developed the first generation of mass-produced "China B-ultrasound" in China, opening the way for the localization of ultrasound diagnostic equipment in my country.
Chaoyan’s product structure is relatively simple. Its main products are medical imaging equipment (including medical ultrasound imaging equipment and portable DR equipment) and industrial non-destructive testing equipment, which are ultimately mainly used for human disease screening and diagnosis and industrial equipment structural flaw detection.
From 2021 to the first half of 2024 (referred to as the "reporting period"), Chaoyan Co., Ltd.'s ultrasound equipment revenue accounted for more than 80% of its main business revenue, of which medical ultrasound equipment contributed more than half of the company's revenue, and industrial ultrasound equipment accounted for about 15% of the revenue. The revenue share of products such as X-rays, medical ultrasound probes, and industrial ultrasound probes was relatively small.
It can be seen that after A-share investors hit the new stocks and sell them on the first day of listing, there is a high probability of making money. Therefore, it is recommended to actively participate in the subscription of the above two new stocks.
The following is an introduction to the specific situation of these two companies.
Chaoyan Co., Ltd. is the "forefather" of ultrasound in my country, with a gross profit margin of over 66%
The full name of Chaoyan Co., Ltd. is "Shantou Ultrasonic dentist data Instrument Research Institute Co., Ltd." and its predecessor is the Ultrasonic Research Institute established in 1982. In 1983, the company independently developed the first generation of mass-produced "China B-ultrasound" in China, opening the way for the localization of ultrasound diagnostic equipment in my country.
Chaoyan’s product structure is relatively simple. Its main products are medical imaging equipment (including medical ultrasound imaging equipment and portable DR equipment) and industrial non-destructive testing equipment, which are ultimately mainly used for human disease screening and diagnosis and industrial equipment structural flaw detection.
From 2021 to the first half of 2024 (referred to as the "reporting period"), Chaoyan Co., Ltd.'s ultrasound equipment revenue accounted for more than 80% of its main business revenue, of which medical ultrasound equipment contributed more than half of the company's revenue, and industrial ultrasound equipment accounted for about 15% of the revenue. The revenue share of products such as X-rays, medical ultrasound probes, and industrial ultrasound probes was relatively small.